TFCHEM

Therapeutic Fluorine Chemistry

Company Drug
Discovery
Supplier
of Services
Expertise
and Mission
Career Press
Review
Contact
The GlycoMim® technology Products Maximizing Portfolio
version française English version
 
The GlycoMim® technology
The GlycoMim® technology: a complete and protected family and a unique know-how.

TFChem has developed the synthetic technology for the preparation of glycoconjugate analogues which are stabilized by innovative fluorinated functional units. This strategy removes a technological lock by solving the stability issues of carbohydrate-based molecules, which is the major limitation to their commercialization.

TFChem develops and markets its GlycoMim® technology for pharmaceutical and biotechnology companies through licensing and strategical partnerships by offering in its portfolio :

- Analogs of existing glycoconjugates.
- Neo-glycosylation of active molecules.
- New chemical entities (NCE) fluoroglycosylated.

Imprint - ©2008